Sandra Levy
ARTICLES BY THIS AUTHOR
- 12/10/2019
Fresenius Kabi debuts generic Invanz
Fresenius Kabi's generic Invanz is available in a 1-g vial. - 12/9/2019
Par launches generic Afinitor
Afinitor 2.5 mg, 5 mg and 7 mg tablets had a market value of roughly $412 million over the last four quarters, according to IQVIA. - 12/9/2019
Pharmacy groups applaud bipartisan drug pricing package
Pharmacy groups applaud the Grassley-Wyden bill, that would address DIR fees, and lower patient costs. - 12/9/2019
Trump, House Democrats reach deal on USMCA trade agreement
House Democrats have secured multiple policy changes in the USMCA, including those related to prescription drug pricing, - 12/8/2019
Amgen gets FDA nod for biosimilar Remicade
Amgen's biosimilar Avsola offers a biological treatment option to patients across critical disease states, including chronic inflammatory conditions. - 12/8/2019
OptumRx acquires Diplomat Pharmacy
Diplomat and OptumRx's combination will expand the innovative specialty pharmacy and infusion solutions that OptumRx can offer. - 12/5/2019
Dr. Reddy's debuts 2 generics
Exjade had a market value of roughly $113 million and Jadenu had a market value of about $470 million for the most recent 12 months ended in September. - 12/5/2019
KPH Healthcare Services, Citizen Advocates to provide behavioral health pharmacy care
Kinnect is a transformational on-site pharmacy option for community health centers, which offers mental health and addiction services. - 12/5/2019
FDA approves first 3 generics of Gilenya
The FDA has approved three applications for first generics of Novartis’ Gilenya (fingolimod) capsules for relapsing forms of multiple sclerosis in adult patients.
